First Time Loading...
M

Maccura Biotechnology Co Ltd
SZSE:300463

Watchlist Manager
Maccura Biotechnology Co Ltd
SZSE:300463
Watchlist
Price: 12.54 CNY 0.08%
Updated: Mar 29, 2024

Intrinsic Value

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. [ Read More ]

The intrinsic value of one Maccura Biotechnology Co Ltd stock under the Base Case scenario is 11.54 CNY. Compared to the current market price of 12.54 CNY, Maccura Biotechnology Co Ltd is Overvalued by 8%.

Key Points:
Intrinsic Value
Base Case
11.54 CNY
Overvaluation 8%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation Backtest
Maccura Biotechnology Co Ltd

Backtest Maccura Biotechnology Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Maccura Biotechnology Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Financials

Balance Sheet Decomposition
Maccura Biotechnology Co Ltd

Current Assets 4.5B
Cash & Short-Term Investments 1.2B
Receivables 1.9B
Other Current Assets 1.4B
Non-Current Assets 3.8B
Long-Term Investments 225.6m
PP&E 2.8B
Intangibles 561.8m
Other Non-Current Assets 194.2m
Current Liabilities 1.2B
Accounts Payable 341.6m
Accrued Liabilities 43.7m
Short-Term Debt 368.8m
Other Current Liabilities 452.3m
Non-Current Liabilities 692.5m
Long-Term Debt 217.1m
Other Non-Current Liabilities 475.3m
Efficiency

Earnings Waterfall
Maccura Biotechnology Co Ltd

Revenue
3B CNY
Cost of Revenue
-1.3B CNY
Gross Profit
1.7B CNY
Operating Expenses
-1.2B CNY
Operating Income
466.9m CNY
Other Expenses
-90.9m CNY
Net Income
376m CNY

Free Cash Flow Analysis
Maccura Biotechnology Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Maccura Biotechnology Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive Operating Income
Positive 3-Year Average ROE
55/100
Profitability
Score

Maccura Biotechnology Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Maccura Biotechnology Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Maccura Biotechnology Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Maccura Biotechnology Co Ltd

Wall Street analysts forecast Maccura Biotechnology Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Maccura Biotechnology Co Ltd is 18.88 CNY with a low forecast of 18.7 CNY and a high forecast of 19.44 CNY.

Lowest
Price Target
18.7 CNY
49% Upside
Average
Price Target
18.88 CNY
51% Upside
Highest
Price Target
19.44 CNY
55% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Maccura Biotechnology Co Ltd

1M 1M
-2%
6M 6M
-16%
1Y 1Y
-32%
3Y 3Y
-69%
5Y 5Y
-35%
10Y 10Y
-1%
Annual Price Range
12.54
52w Low
10.3
52w High
18.62
Price Metrics
Average Annual Return 7.1%
Standard Deviation of Annual Returns 51.16%
Max Drawdown -83%
Shares Statistics
Market Capitalization 7.6B CNY
Shares Outstanding 612 469 590
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Maccura Biotechnology Co Ltd

Country

China

Industry

Life Sciences Tools & Services

Market Cap

7.6B CNY

Dividend Yield

2.79%

Description

Maccura Biotechnology Co., Ltd. engages in the research, development, production, sale, and service of in vitro diagnostic products. The company is headquartered in Chengdu, Sichuan and currently employs 2,901 full-time employees. The company went IPO on 2015-05-28. The firm provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.

Contact

SICHUAN
Chengdu
No. 8 Anhe Second Road, High-tech Zone
+862881731186
http://www.maccura.com

IPO

2015-05-28

Employees

2 901

Officers

GM & Director
Mr. Wu Mingjian
CFO & Director
Ms. Shan Yin
Administrative Director & Manager of Human Resource Department
Ms. Ping Yu
Director of Marketing & Director
Mr. Shengguo Xu
Secretary & Director of Strategic Investment
Ms. Wei Shi
Director of Production - Reagents
Ms. Hui Yang

See Also

Discover More
What is the Intrinsic Value of one Maccura Biotechnology Co Ltd stock?

The intrinsic value of one Maccura Biotechnology Co Ltd stock under the Base Case scenario is 11.54 CNY.

Is Maccura Biotechnology Co Ltd stock undervalued or overvalued?

Compared to the current market price of 12.54 CNY, Maccura Biotechnology Co Ltd is Overvalued by 8%.